Ignite Creation Date:
2025-12-25 @ 12:24 AM
Ignite Modification Date:
2026-01-06 @ 3:28 AM
Study NCT ID:
NCT06487858
Status:
RECRUITING
Last Update Posted:
2025-12-08
First Post:
2024-06-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors
Sponsor:
BeOne Medicines
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BGB-R046-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None